BY002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BY002, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: BY002 IIT Study in R/R Acute Leukemia [Phase 1]
1 regulatory and trial event tracked for BY002, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: BY002 IIT Study in R/R Acute Leukemia [Phase 1]